HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wanzhen Xu Selected Research
Wanzhen Xu Research Topics
Disease
4
Neoplasms (Cancer)
01/2024 - 01/2017
2
Glioma (Gliomas)
01/2024 - 01/2022
2
Glioblastoma (Glioblastoma Multiforme)
01/2017 - 01/2017
1
Neoplasm Metastasis (Metastasis)
01/2024
1
Inflammation (Inflammations)
04/2023
1
Sepsis (Septicemia)
04/2023
1
Sarcopenia
04/2023
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2021
1
Subdural Hematoma (Subdural Hemorrhage)
02/2021
1
Hematoma
02/2021
1
Astrocytoma (Pilocytic Astrocytoma)
01/2017
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2024 - 01/2022
1
Cholinergic Receptors
IBA
01/2024
1
Interleukin-6 (Interleukin 6)
IBA
01/2024
1
Messenger RNA (mRNA)
IBA
01/2024
1
RNA (Ribonucleic Acid)
IBA
01/2024
1
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
01/2024
1
sulforaphane
IBA
04/2023
1
Lipopolysaccharides
IBA
04/2023
1
Toll-Like Receptor 4
IBA
04/2023
1
Inflammasomes
IBA
04/2023
1
Chemokines
IBA
01/2022
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2022
1
Chemokine Receptors
IBA
01/2022
1
Temozolomide (Temodar)
FDA Link
Generic
01/2017
1
DNA (Deoxyribonucleic Acid)
IBA
01/2017
1
Aurora Kinase A
IBA
01/2017
1
N-phthaloylglutamic acid
IBA
01/2017
Therapy/Procedure
2
Drug Therapy (Chemotherapy)
01/2024 - 01/2017
1
Immunotherapy
01/2024
1
Craniotomy
02/2021